“NanoGAS” was registered as a trademark.
We are pleased to announce that “NanoGAS” (read: nano-gas), for which Symbiosis, Inc. filed an application with the Japan Patent Office, was registered as a trademark on August 19, 2021.
Synbiosis’ proprietary Ultra Fine Bubble (UFB) water containing invisible microscopic bubbles is called “NanoGAS®” and this technology is also used in the bacterial solution for intestinal flora transplantation used in our research group. (Patent pending)
By utilizing the properties of Ultra Fine Bubble, we expect to effectively transfer intestinal bacteria of other people’s origin, which were originally considered to be blocked by autoimmune functions such as IgA (immunoglobulin A) and could not successfully take up residence.
In addition, we recommend drinking “Hydrogen NanoGAS® Water” as a medical aid for transplantation.
Thank you for your continued support of the Intestinal Flora Transplant Clinical Research Group and Symbiosis, Inc.
その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports
April 03, 2024
【Event】 Dr. Shirotani will speak at the 7th Annual Conference of the Japanese Society of Preemptive Clinical Medicine
Dr. Masahiko Shirotani, Executive Director of the Luke’s Ashiya Clinic, will deliver a special lecture at the 7th Annual Conference of the Japanese Society of Preemptive Medicine to be held on June 22 (Sat.) and 23 (Sun.), 2024. Dr. Zen Tanaka, President of Tanaka Clinic, Nizenkai Medical Corporation, will be the chairperson. Lecture Contents Special […]
March 04, 2024
〈Registration Start〉8th Annual Conference
We are pleased to announce that the 8th Annual Conference will be held again this year. (Venue and online)Anyone is welcome to attend, not only healthcare professionals, but also the general public, students, etc. Date and Time Sunday, September 22, 2024Start 11:00 am (Registration 10:30 am) – Closing at 5:00 pm *General Meeting: Held before […]
February 04, 2024
Interview with Goro Tsukamoto at the 7th Annual Meeting
‘Gut Flora Transplantation Clinical Study Group of Experts〜Aiming for easier access to treatment, we are challenging research and development.Pharmacist, Doctor of Engineering Goro Tsukamoto: Former Director and General Manager of Drug Discovery Research Institute, Bell Boss, Former Visiting Professor, University of Pittsburgh, USA, Former Professor, Nagaoka University of Technology The world’s first migraine drug, invented […]
